InvestorsHub Logo
Followers 827
Posts 119484
Boards Moderated 15
Alias Born 09/05/2002

Re: Bickema post# 474

Thursday, 07/14/2016 2:52:19 PM

Thursday, July 14, 2016 2:52:19 PM

Post# of 592
Kangio does not infringe any of MDCO's remaining Angiomax patents, so EGRX will almost certainly launch Kangio as soon as the FDA approves it.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EGRX News